financial results

Sopharma Trading is one of the largest Bulgarian companies. As long as several years it was ranked at first place by revenue in the Pharmaceutical sector in Capital Top 100.

Financial data January-September 2017
Sales – BGN 672 145 000, growth of 10% compared to 2016
Profit before taxes – BGN 16 242 000, growth of 9% compared to 2016

Financial Data about 2016:
Revenue from sales - 612 734 000 BGN, growth of 2% compared to 2015
Profit before taxation - 14 826 000 BGN, growth of  9% compared to 2015
 
Financial Data about 2015:
Revenue from sales 603 410 000 BGN, growth of 5% compared to 2014
Profit before taxation - 12 164000 BGN, growth of 14% compared to 2014

Financial Data about 2014:
Revenue from sales - 576 100 000 BGN, growth of 14% compared to 2013
Profit before taxation - 11 861 000 BGN, growth of 12% compared to 2013
 
Financial Data about 2013:
Revenue from sales - 507 027 000 BGN, growth of 10% compared to 2012
Profit before taxation -10 580 000 BGN, growth of 29% compared to 2012
 
Financial data about 2012
Income from sales – 462 529 000 BGN, growth of 4% compared to 2011
Profit before taxation – 8 181 000 BGN, growth of 14% compared to 2011
 
Financial data about 2011
Income from sales – 444 616 000 BGN, growth of 11% compared to 2010
Profit before taxation – 7 150 000 BGN, growth of 4% compared to 2010
Total market share on the pharmaceutical market: 22%
 
Financial data about 2010
Income from sales – 400 449 000 BGN, growth of 14% compared to 2009
Total market share on the pharmaceutical market - 21.7 %
Profit before taxation – 6 843 000, growth of 53% compared to 2009